MURA logo

Mural Oncology (MURA) EBITDA

Annual EBITDA

-$134.75 M
+$58.92 M+30.42%

December 31, 2024


Summary


Performance

MURA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMURAprofitabilitymetrics:

Quarterly EBITDA

-$34.99 M
-$1.79 M-5.38%

December 31, 2024


Summary


Performance

MURA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMURAprofitabilitymetrics:

TTM EBITDA

-$134.75 M
+$22.91 M+14.53%

December 31, 2024


Summary


Performance

MURA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMURAprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MURA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.4%+39.6%+30.4%
3 y3 years+22.5%+24.9%+27.6%
5 y5 years+22.5%+24.9%+27.6%

MURA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+30.4%-5.4%+39.6%-175.4%+30.4%
5 y5-yearat high+30.4%-5.4%+39.6%-175.4%+30.4%
alltimeall timeat high+30.4%-5.4%+39.6%-175.4%+30.4%

Mural Oncology EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$134.75 M(-30.4%)
-$34.99 M(+5.4%)
-$134.75 M(-14.5%)
Sep 2024
-
-$33.20 M(-0.5%)
-$157.66 M(-7.3%)
Jun 2024
-
-$33.38 M(+0.6%)
-$170.00 M(-7.2%)
Mar 2024
-
-$33.19 M(-42.7%)
-$183.23 M(-5.4%)
Dec 2023
-$193.67 M
-$57.90 M(+27.2%)
-$193.67 M(+6.0%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$45.53 M(-2.3%)
-$182.64 M(-1.8%)
Jun 2023
-
-$46.61 M(+6.8%)
-$186.03 M(+33.4%)
Mar 2023
-
-$43.63 M(-6.9%)
-$139.42 M(+45.5%)
Dec 2022
-$183.38 M(+5.5%)
-$46.87 M(-4.2%)
-$95.80 M(+95.8%)
Sep 2022
-
-$48.93 M
-$48.93 M
Dec 2021
-$173.89 M
-
-

FAQ

  • What is Mural Oncology annual EBITDA?
  • What is the all time high annual EBITDA for Mural Oncology?
  • What is Mural Oncology annual EBITDA year-on-year change?
  • What is Mural Oncology quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Mural Oncology?
  • What is Mural Oncology quarterly EBITDA year-on-year change?
  • What is Mural Oncology TTM EBITDA?
  • What is the all time high TTM EBITDA for Mural Oncology?
  • What is Mural Oncology TTM EBITDA year-on-year change?

What is Mural Oncology annual EBITDA?

The current annual EBITDA of MURA is -$134.75 M

What is the all time high annual EBITDA for Mural Oncology?

Mural Oncology all-time high annual EBITDA is -$134.75 M

What is Mural Oncology annual EBITDA year-on-year change?

Over the past year, MURA annual EBITDA has changed by +$58.92 M (+30.42%)

What is Mural Oncology quarterly EBITDA?

The current quarterly EBITDA of MURA is -$34.99 M

What is the all time high quarterly EBITDA for Mural Oncology?

Mural Oncology all-time high quarterly EBITDA is -$33.19 M

What is Mural Oncology quarterly EBITDA year-on-year change?

Over the past year, MURA quarterly EBITDA has changed by +$22.91 M (+39.57%)

What is Mural Oncology TTM EBITDA?

The current TTM EBITDA of MURA is -$134.75 M

What is the all time high TTM EBITDA for Mural Oncology?

Mural Oncology all-time high TTM EBITDA is -$48.93 M

What is Mural Oncology TTM EBITDA year-on-year change?

Over the past year, MURA TTM EBITDA has changed by +$58.92 M (+30.42%)